PURPOSE: Keratoconus (KTCN) is a noninflammatory thinning and anterior protrusion of the cornea that results in steepening and distortion of the cornea, altered refractive powers, and reduced visual acuity. Several loci responsible for a familial form of KTCN have been mapped, however; no mutations in any genes have been identified for any of these loci. There is also evidence that VSX1 and SOD1 may be involved in the etiology of KTCN. The purpose of this study was to verify the available data and to identify a new keratoconus susceptibility locus. METHODS: KTCN without other ocular or systemic features was diagnosed in 18 families. VSX1 and SOD1 sequencing was performed on affected individuals and control subjects. Genomewide linkage analysis was then performed in all families using polymorphic microsatellite markers with an average spacing of 5 cM. Next, single-nucleotide polymorphism (SNP) arrays, fluorescence in situ hybridization (FISH) analysis, and a comparative genomic hybridization array were used in one family to assess a candidate region on 13q32. RESULTS: All previously reported KTCN loci were excluded. VSX1 and SOD1 were sequenced, and no potentially functional variants were found. One KTCN family yielded a maximum multipoint parametric LOD score of 4.1 and multipoint nonparametric linkage (NPL) LOD score of 3.2. Multipoint linkage and haplotype analysis narrowed the locus to a 5.6-Mb region between the SNPs rs9516572 and rs3825523 on 13q32. CONCLUSIONS: The results exclude VSX1 and SOD1 as potential disease-causing genes in these families and localize a novel gene for keratoconus to a 5.6-Mb interval on 13q32.
PURPOSE: Keratoconus (KTCN) is a noninflammatory thinning and anterior protrusion of the cornea that results in steepening and distortion of the cornea, altered refractive powers, and reduced visual acuity. Several loci responsible for a familial form of KTCN have been mapped, however; no mutations in any genes have been identified for any of these loci. There is also evidence that VSX1 and SOD1 may be involved in the etiology of KTCN. The purpose of this study was to verify the available data and to identify a new keratoconus susceptibility locus. METHODS: KTCN without other ocular or systemic features was diagnosed in 18 families. VSX1 and SOD1 sequencing was performed on affected individuals and control subjects. Genomewide linkage analysis was then performed in all families using polymorphic microsatellite markers with an average spacing of 5 cM. Next, single-nucleotide polymorphism (SNP) arrays, fluorescence in situ hybridization (FISH) analysis, and a comparative genomic hybridization array were used in one family to assess a candidate region on 13q32. RESULTS: All previously reported KTCN loci were excluded. VSX1 and SOD1 were sequenced, and no potentially functional variants were found. One KTCN family yielded a maximum multipoint parametric LOD score of 4.1 and multipoint nonparametric linkage (NPL) LOD score of 3.2. Multipoint linkage and haplotype analysis narrowed the locus to a 5.6-Mb region between the SNPs rs9516572 and rs3825523 on 13q32. CONCLUSIONS: The results exclude VSX1 and SOD1 as potential disease-causing genes in these families and localize a novel gene for keratoconus to a 5.6-Mb interval on 13q32.
Authors: Anne E Hughes; Durga P Dash; A Jonathan Jackson; David G Frazer; Giuliana Silvestri Journal: Invest Ophthalmol Vis Sci Date: 2003-12 Impact factor: 4.799
Authors: Henna Tyynismaa; Pertti Sistonen; Sari Tuupanen; Timo Tervo; Anja Dammert; Terho Latvala; Tiina Alitalo Journal: Invest Ophthalmol Vis Sci Date: 2002-10 Impact factor: 4.799
Authors: Kathryn P Burdon; Stuart Macgregor; Yelena Bykhovskaya; Sharhbanou Javadiyan; Xiaohui Li; Kate J Laurie; Dorota Muszynska; Richard Lindsay; Judith Lechner; Talin Haritunians; Anjali K Henders; Durga Dash; David Siscovick; Seema Anand; Anthony Aldave; Douglas J Coster; Loretta Szczotka-Flynn; Richard A Mills; Sudha K Iyengar; Kent D Taylor; Tony Phillips; Grant W Montgomery; Jerome I Rotter; Alex W Hewitt; Shiwani Sharma; Yaron S Rabinowitz; Colin Willoughby; Jamie E Craig Journal: Invest Ophthalmol Vis Sci Date: 2011-10-31 Impact factor: 4.799
Authors: Michal Kabza; Justyna A Karolak; Malgorzata Rydzanicz; Michał W Szcześniak; Dorota M Nowak; Barbara Ginter-Matuszewska; Piotr Polakowski; Rafal Ploski; Jacek P Szaflik; Marzena Gajecka Journal: Eur J Hum Genet Date: 2017-02-01 Impact factor: 4.246
Authors: Geoffrey D Lively; Demelza Koehn; Adam Hedberg-Buenz; Kai Wang; Michael G Anderson Journal: Physiol Genomics Date: 2010-04-27 Impact factor: 3.107
Authors: Marta Czugala; Justyna A Karolak; Dorota M Nowak; Piotr Polakowski; Jose Pitarque; Andrea Molinari; Malgorzata Rydzanicz; Bassem A Bejjani; Beatrice Y J T Yue; Jacek P Szaflik; Marzena Gajecka Journal: Eur J Hum Genet Date: 2011-11-02 Impact factor: 4.246
Authors: Fernanda T Bellucco; Hélio Rodrigues de Oliveira-Júnior; Roberta Santos Guilherme; Silvia Bragagnolo; Ana B Alvarez Perez; Vera Ayres Meloni; Maria I Melaragno Journal: Mol Syndromol Date: 2019-03-06
Authors: Justyna A Karolak; Karolina Kulinska; Dorota M Nowak; Jose A Pitarque; Andrea Molinari; Malgorzata Rydzanicz; Bassem A Bejjani; Marzena Gajecka Journal: Mol Vis Date: 2011-03-30 Impact factor: 2.367